| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5845758 | Pulmonary Pharmacology & Therapeutics | 2013 | 5 Pages |
Abstract
Our results suggest that indacaterol could be a useful option in the treatment of AECOPD. However, further larger double-blinded randomized clinical trials are needed to validate the intriguing results obtained in this setting.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Andrea Segreti, Enrica Fiori, Luigino Calzetta, Marco Sabatini, Vincenzo Segreti, Paola Rogliani, Mario Cazzola,